Which Starter Dose Offers Better Value for Your Goals?
Wegovy vs Mounjaro Starter Dose: Understanding Your Options
When comparing Wegovy and Mounjaro starter doses, the fundamental difference lies in their mechanisms and initial pricing structures. Wegovy (semaglutide) is a GLP-1 receptor agonist that starts at 0.25mg, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, beginning at 2.5mg with a different approach to appetite regulation.
The wegovy comparison price analysis reveals distinct advantages for each treatment's starter phase. Wegovy's 0.25mg starter dose allows for gentler introduction to GLP-1 therapy, potentially reducing initial side effects whilst your body adjusts to the medication. Mounjaro's 2.5mg starting dose reflects its dual-hormone approach, targeting both GLP-1 and GIP receptors from the outset. Both require careful dose escalation under medical supervision, making the choice of starter dose crucial for your treatment journey.
Starter Dose Pricing: Wegovy vs Mounjaro Value Analysis
The wegovy comparison price for starter doses shows clear distinctions between these prescription-only medicines. Wegovy's 0.25mg starter pen costs £79.99 at EverydayMeds, providing four weeks of initial treatment during weeks 1-4 of your journey. Our Intro Duo bundle pairs the 0.25mg starter with 0.5mg for weeks 5-8, totalling £169.99 for your first two months of treatment.
Mounjaro's starter pricing follows a different structure, with 2.5mg pens requiring separate cost consideration. Both treatments are available through our GPhC-registered pharmacy (#9012878) with identical service standards including clinical assessment, prescriber review, and next-day cold-chain delivery. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive starter prices.
Clinical Evidence Supporting Starter Dose Selection
The STEP trials demonstrated Wegovy's efficacy when patients began with the 0.25mg starter dose, with participants achieving approximately 15% average weight loss at 68 weeks versus 2.4% with placebo. This gradual dose escalation from 0.25mg helps optimise tolerability whilst building therapeutic effect over the 16-week escalation period.
Mounjaro's clinical evidence from the SURMOUNT trials shows the importance of starting with 2.5mg before escalating to higher doses. Both wegovy comparison price considerations must account for the complete dose escalation journey, not just starter costs, as cited in Wilding et al., NEJM, 2021 for Wegovy's comprehensive clinical profile.
How These Starter Doses Work in Your System
Wegovy's 0.25mg starter dose begins working by binding to GLP-1 receptors in your brain's appetite centres, gradually reducing hunger signals and increasing feelings of fullness after meals. This once-weekly injection using the FlexTouch pen system delivers consistent semaglutide levels throughout the week, with effects building progressively. The starter dose allows your digestive system to adapt to slower gastric emptying, potentially minimising nausea that some patients experience. Mounjaro's 2.5mg starter targets both GLP-1 and GIP receptors simultaneously, offering a dual-hormone approach from treatment initiation. Both medications work most effectively when combined with reduced-calorie diet and increased physical activity as part of comprehensive weight management.
Getting Started: Assessment to Delivery Process
Beginning your wegovy comparison price evaluation starts with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining whether Wegovy or Mounjaro starter doses suit your individual circumstances. Once approved, your chosen starter dose ships via next-day delivery using temperature-controlled packaging to maintain medication integrity. The FlexTouch pen system requires no mixing or preparation - simply attach a new needle, dial your prescribed dose, and inject subcutaneously once weekly. Both Wegovy and Mounjaro include comprehensive patient information leaflets and injection technique guidance to ensure confident self-administration from your first starter dose.
Storage and Practical Considerations for Starter Doses
Wegovy starter pens require refrigeration at 2-8°C before first use, but offer significant travel convenience with 6 weeks of room temperature storage below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with limited refrigeration access. The FlexTouch pen system delivers precise 0.25mg doses with an easy-to-read dose counter and automatic needle coverage post-injection. Your starter dose pen contains four weekly injections, with clear markings to track your progression through the initial treatment phase. Proper disposal through pharmacy take-back programmes ensures safe handling of used injection pens throughout your dose escalation journey.
Why Starter Dose Choice Matters for Long-term Success
The wegovy comparison price analysis extends beyond initial costs to consider treatment sustainability and progression pathways. Wegovy's gentle 0.25mg introduction allows patients to build confidence with self-injection whilst minimising gastrointestinal side effects that might otherwise compromise treatment adherence. This measured approach to GLP-1 therapy often translates to better long-term outcomes as patients develop sustainable habits alongside their medication routine.
Mounjaro's 2.5mg starter dose reflects its dual-hormone mechanism, potentially offering faster initial appetite suppression for patients who tolerate GLP-1 effects well. Both treatments require commitment to the full dose escalation schedule - you cannot skip doses or rush the process without compromising both safety and effectiveness. The starter dose choice should align with your tolerance profile, lifestyle factors, and long-term weight management objectives as determined through clinical assessment.
Making Your Decision: Next Steps and Support
Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which starter dose aligns with your individual circumstances and treatment goals. Our clinical team provides ongoing support throughout your dose escalation journey, ensuring you understand injection techniques, side effect management, and treatment optimisation strategies. The wegovy comparison price evaluation should consider total treatment costs, storage requirements, and your personal response to GLP-1 therapy as treatment progresses. Complete your clinical assessment today to begin discussing starter dose options with our qualified prescribers, taking advantage of new customer pricing with code FIRST40 or returning customer benefits with DOSE25. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to start your weight management journey with transparent pricing and professional clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
